Arcturus Therapeutics股价因OTC缺乏症试验数据积极而上涨

英为财情
Jun 30, 2025

Investing.com -- Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)股价上涨2%,此前该公司两项针对鸟氨酸转氨甲酰酶(OTC)缺乏症的ARCT-810 mRNA疗法的第2期临床试验取得积极中期结果。 该公司报告称,ARCT-810在两项研究中均显示出显著的生物学效应,包括持续降低并使升高的谷氨酰胺水平正常化,谷氨酰胺是尿素循环功能的重要...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10